Stephane Lajoie

Stephane Lajoie

Auto-generated profile, based on publicly available information

Stephane Lajoie

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2010 in Nature Immunology
Verified
Journal Article
Open access
PDF file
SLStephane Lajoie
Stephane Lajoie
ILIan P Lewkowich
Ian P Lewkowich
YSYusuke Suzuki
Yusuke Suzuki
JCJennifer R Clark
Jennifer R Clark
ASAlyssa A Sproles
Alyssa A Sproles
MWMarsha Wills-Karp
Marsha Wills-Karp
Greater production of interleukin 17A is associated with severe asthma. Wills-Karp and colleagues show that the complement anaphylatoxins C3a and C5a have opposing roles in enhancing or suppressing IL-17a in allergic asthma. Severe asthma is associated with the production of interleukin 17A (IL-17A). The exact role of IL-17A in severe asthma and the factors that drive its production are unknown. Here we demonstrate that IL-17A mediated severe airway hyperresponsiveness (AHR) in susceptible strains of mice by enhancing IL-13-driven responses. Mechanistically, we demonstrate that IL-17A and AHR were regulated by allergen-driven production of anaphylatoxins, as mouse strains deficient in complement factor 5 (C5) or the complement receptor C5aR mounted robust IL-17A responses, whereas mice deficient in C3aR had fewer IL-17-producing helper T cells (TH17 cells) and less AHR after allergen challenge. The opposing effects of C3a and C5a were mediated through their reciprocal regulation of IL-23 production. These data demonstrate a critical role for complement-mediated regulation of the IL-23–TH17 axis in severe asthma.

22 June 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
USUrsula Smole
Ursula Smole
NGNaina Gour
Naina Gour
JPJordan Phelan
Jordan Phelan
GHGerhard Hofer
Gerhard Hofer
CKCordula Köhler
Cordula Köhler
MWMarsha Wills-Karp
Marsha Wills-Karp

8 December 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ILIan P. Lewkowich
Ian P. Lewkowich
SLStephane Lajoie
Stephane Lajoie
JCJennifer R. Clark
Jennifer R. Clark
NHNancy S. Herman
Nancy S. Herman
ASAlyssa A. Sproles
Alyssa A. Sproles
MWMarsha Wills-Karp
Marsha Wills-Karp
Maladaptive, Th2-polarized inflammatory responses are integral to the pathogenesis of allergic asthma. As regulators of T cell activation, dendritic cells (DCs) are important mediators of allergic asthma, yet the precise signals which render endogenous DCs “pro-asthmatic”, and the extent to which these signals are regulated by the pulmonary environment and host genetics, remains unclear. Comparative phenotypic and functional analysis of pulmonary DC populations in mice susceptible (A/J), or resistant (C3H) to experimental asthma, revealed that susceptibility to airway hyperresponsiveness is associated with preferential myeloid DC (mDC) allergen uptake, and production of Th17-skewing cytokines (IL-6, IL-23), whereas resistance is associated with increased allergen uptake by plasmacytoid DCs. Surprisingly, adoptive transfer of syngeneic HDM-pulsed bone marrow derived mDCs (BMDCs) to the lungs of C3H mice markedly enhanced lung IL-17A production, and rendered them susceptible to allergen-driven airway hyperresponsiveness. Characterization of these BMDCs revealed levels of antigen uptake, and Th17 promoting cytokine production similar to that observed in pulmonary mDCs from susceptible A/J mice. Collectively these data demonstrate that the lung environment present in asthma-resistant mice promotes robust pDC allergen uptake, activation, and limits Th17-skewing cytokine production responsible for driving pathologic T cell responses central to the development of allergen-induced airway hyperresponsiveness.

29 January 2015 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
JMJaclyn W. McAlees
Jaclyn W. McAlees
SLStephane Lajoie
Stephane Lajoie
KDKrista Dienger
Krista Dienger
ASAlyssa A. Sproles
Alyssa A. Sproles
PRPhoebe K. Richgels
Phoebe K. Richgels
ILIan P. Lewkowich
Ian P. Lewkowich
Studies examining the role of PD‐1 family members in allergic asthma have yielded conflicting results. Using a mouse model of allergic asthma, we demonstrate that blockade of PD‐1/PD‐L1 has distinct influences on different CD4+ T‐cell subsets. PD‐1/PD‐L1 blockade enhances airway hyperreactivity (AHR), not by altering the magnitude of the underlying Th2‐type immune response, but by allowing the development of a concomitant Th17‐type immune response. Supporting differential CD4+ T‐cell responsiveness to PD‐1‐mediated inhibition, naïve PD‐1−/− mice displayed elevated Th1 and Th17 levels, but diminished Th2 cytokine levels, and ligation of PD‐1 in WT cells limited cytokine production by in vitro polarized Th1 and Th17 cells, but slightly enhanced cytokine production by in vitro polarized Th2 cells. Furthermore, PD‐1 ligation enhanced Th2 cytokine production by naïve T cells cultured under nonpolarizing conditions. These data demonstrate that different CD4+ T‐cell subsets respond differentially to PD‐1 ligation and may explain some of the variable results observed in control of allergic asthma by the PD‐1 family members. As the PD‐1/PD‐L1 axis limits asthma severity by constraining Th17 cell activity, this suggests that severe allergic asthma may be associated with a defective PD‐1/PD‐L1 regulatory axis in some individuals.

1 February 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
SHSara L. Hall
Sara L. Hall
TBTheresa Baker
Theresa Baker
SLStephane Lajoie
Stephane Lajoie
PRPhoebe K. Richgels
Phoebe K. Richgels
YYYanfen Yang
Yanfen Yang
ILIan P. Lewkowich
Ian P. Lewkowich

9 February 2018 in Science Immunology
Verified
Journal Article
Closed access
PDF file
NGNaina Gour
Naina Gour
SLStephane Lajoie
Stephane Lajoie
USUrsula Smole
Ursula Smole
MWMarquitta White
Marquitta White
DHDonglei Hu
Donglei Hu
MWMarsha Wills-Karp
Marsha Wills-Karp
Invertebrate tropomyosin homologs are ligands for dectin-1.